ArticleMolecular cancer therapeutics2014

Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.

Hong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.